1/22/2024 0 Comments Novavax eu![]() ![]() The Nuvaxovid vaccine is more accurately described as a protein vaccine, which in contrast to classical vaccines is genetically produced and contains minuscule particles from a version of the virus’s spike protein grown in moth cells in the laboratory that prompt the formation of antibodies in an individual. In November, Karl Lauterbach, the then health spokesperson for the Social Democratic party, who has since become the health minister, said that because of the popular use of the term “dead vaccine” among vaccine-hesitant Germans, the term would also generally be applied by health experts. ![]() The new Covid jabs made by Novavax and the French-Austrian manufacturer Valneva, whose VLA2001 is also based on the more conventional method, are typically characterised as a Totimpfstoff, or “dead vaccine”, even though experts say the term is not scientifically accurate. In fact, the number of side-effects suffered has been very low despite the billions who have already taken the vaccines worldwide, as the head of the Robert Koch Institute, the German government’s disease control agency, has repeatedly said. Reluctance in Germany and other German-speaking countries to take the novel mRNA vaccines is put down to mistrust in the new technology, with people mainly citing safety concerns about side-effects or long-term health impacts, largely because of the apparent speed with which they were introduced. It has been found to have an efficacy of over 90% in preventing symptomatic infection with the Alpha variant, and is currently undergoing further tests to check its ability to protect against the Omicron variant. While those four simulate a virus in the body, Nuvaxovid uses a more traditional type of technology. It is making its appearance in the battle against the virus about a year after the novel mRNA vaccines produced by Pfizer/BioNTech and Moderna, and the viral vector vaccines made by Oxford/AstraZeneca and Johnson & Johnson. The rollout of the vaccine – called Nuvaxovid – by the US-based drugmaker Novavax has been repeatedly hampered by a series of lengthy delays including production issues. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |